A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors.
A2 engineers T cells that target the loss of genetic material in tumors, enabling the selective killing of tumor cells while leaving normal cells unharmed.
The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and has raised $136M since inception. Our investors include The Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments (Office of the Chief Investment Officer of the Regents) and Hartford HealthCare Endowment.
Location: United States, California, Agoura Hills
Employees: 51-200
Total raised: $128.5M
Founded date: 2018
Investors 1
Funding Rounds 2
Date | Series | Amount | Investors |
06.10.2020 | Series B | $71.5M | - |
05.11.2019 | Series A | $57M | - |
Mentions in press and media 9
Date | Title | Description | Source |
23.12.2020 | A2 Biotherapeutics Enters Into Collaboration Agreement With ... | Deal enables A2 to build allogeneic capability AGOURA HILLS, Calif.–(BUSINESS WIRE)–December 23, 20... | venturebea... |
23.12.2020 | News briefing: Merck buys into A2's T cell therapy plat... | Merck is dipping its toes into a cell therapy partnership with A2 Biotherapeutics, with a... | endpts.com... |
23.12.2020 | A2 Biotherapeutics Enters Into Collaboration Agreement With ... | AGOURA HILLS, Calif., Dec. 23, 2020 /PRNewswire/ -- A2 Biotherapeutics (www.a2bio.com), a biotechn... | prnewswire... |
07.10.2020 | A2 Biotherapeutics Closes $71.5M Series B Funding | A2 Biotherapeutics, a Agoura Hills, Calif.-based biotechnology company developing innovative cell th... | finsmes.co... |
06.10.2020 | A2 Biotherapeutics Closes $71.5M Series B to Begin Clinical ... | AGOURA HILLS, Calif.–(BUSINESS WIRE)–October 6, 2020– A2 Biotherapeutics (www.a2bio.com), a biotech... | venturebea... |
06.10.2020 | A2 Biotherapeutics Closes $71.5M Series B To Begin Clinical ... | AGOURA HILLS, Calif., Oct. 6, 2020 /PRNewswire/ -- A2 Biotherapeutics (www.a2bio.com), a biotechno... | prnewswire... |
06.11.2019 | A2 Biotherapeutics, Founded By Amgen Vets, Gets $57M For... | Agoura Hills-based A2 Biotherapeutics, a biotechnology firm started by veterans of Amgen which is de... | socaltech.... |
05.11.2019 | A2 Biotherapeutics Raises $57M in Series A Funding | A2 Biotherapeutics, an Agoura Hills, Calif.-based biotechnology company developing innovative cell t... | finsmes.co... |
05.11.2019 | A2 Biotherapeutics Emerges From Stealth Mode With $57M Serie... | AGOURA HILLS, Calif.–(BUSINESS WIRE)–November 5, 2019– A2 Biotherapeutics (www.a2bio.com), a biotec... | venturebea... |